Skip to main content

Retail Clinics

  • Diabetes prevalence among Americans may increase to 33%, CDC study finds

    ATLANTA The rate of diabetes among Americans is on an upswing and likely will reach epic proportions by 2050, costing the government millions.

     

  • New Lo Loestrin Fe gets FDA approval

    ARDEE, Ireland The Food and Drug Administration has approved a new contraceptive from Warner Chilcott, the drug maker said Friday.

     

    The company said it plans to launch Lo Loestrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) early next year. The company said the contraceptive contains the lowest dosage of estrogen — 10 micrograms — of any oral contraceptive currently available in the U.S. market.

     

     

  • In study, insurer shows cost benefits of smarter health decisions by patients

    BLOOMFIELD, Conn. Americans can lower their total medical costs significantly by taking simple steps to prevent or manage disease and by switching to generic drugs whenever possible, new research from health insurance giant Cigna confirmed.

  • FDA approves Actavis' generic Ambien CR

    MORRISTOWN, N.J. The Food and Drug Administration has approved a drug for treating insomnia made by Actavis, the generic drug maker said Monday.

     

    Actavis announced the approval of zolpidem tartrate extended-release tablets in the 6.25-mg strength. The company has begun shipping the drug.

     

     

    The drug is a generic version of Sanofi-Aventis’ Ambien CR, which had sales of around $129 million during the 12-month period ended in June, according to IMS Health.

     

  • Dr. Reddy's to launch generic Prevacid

    HYDERABAD, India Dr. Reddy's disclosed on Tuesday it will market a generic peptic ulcer treatment.

    Dr. Reddy's lansoprazole delayed-release capsules will be available in 15-mg and 30-mg strengths, the drug maker said. The capsules are the generic version of Takeda's Prevacid delayed-release capsules.

    The FDA approved Dr. Reddy’s abbreviated new drug application for the drug on Oct. 15.

  • American Diabetes Association continues to raise awareness as celebratory month nears

    ALEXANDRIA, Va. American Diabetes Month will be celebrated this November, and the group leading the fight to end the disease is encouraging others to join the movement.

     

    Shortly after announcing that "Celebrity Apprentice" winner and Poison frontman Bret Michaels joined its "Stop Diabetes" movement, the American Diabetes Association has launched the "Share Your Vision to Stop Diabetes" video contest, and has asked Americans to:

  • McNeil recalls one lot of Tylenol

    FORT WASHINGTON, Pa. McNeil Consumer Healthcare has pulled a lot of Tylenol off the market, following complaints of a musty odor.

    McNeil said the uncharacteristic odor is thought to be caused by the presence of trace amounts of a chemical called 2,4,6-tribromoanisole. The lot of Tylenol 8-Hour, 50-count bottles are part of lot number BCM155 and carry the following UPC code: 3 0045-0297-51 8.

  • Teva, Sandoz launch Prevacid SoluTab generics

    JERUSALEM The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market a generic version of a drug designed to treat peptic ulcers.

    The generic drug maker said that its drug, lansoprazole, is a generic version of Takeda’s Prevacid SoluTab. Annual sales of the branded product were approximately $453 million in the United States, according to IMS sales data.

    Sandoz, the generics division of Swiss drug maker Novartis, also announced the launch of its own version of Prevacid SoluTab.

X
This ad will auto-close in 10 seconds